The dysregulation in the PI3K/PTEN/Akt/mTOR pathway also promotes the metabolic shifting to glycolysis, thus reducing the efficacy of 5-FU by decreasing its absorption, due to acidification of the tumour microenvironment, as well as hindering cell apoptosis [16,49,50]. This evidence concerns the gene AKT1 and neoplasm.